Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Azetidinecarboxamide derivatives for the treatment of CNS disorders

Azetidinecarboxamide derivatives for the treatment of CNS disorders

US Patent 6514961 · Granted Feb 4, 2003

Estimated economic value: $67,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl inhibitors of PAD42021
Use of VAP-1 inhibitors for treating fibrotic conditions2020
Sepiapterin reductase inhibitors2018
Use of VAP-1 inhibitors for treating fibrotic conditions2017
Therapeutic aryl-amido-aryl compounds and their use2016
Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity2009
Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor 2009
Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity2008
Condensed indoline derivatives and their use as 5-HT, in particular 5-HT2C, rece2008
Condensed indoline derivatives and their use as 5-HT, in particular 5-HT2C, rece2008
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, recept2008
Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, recept2008